PAK3 and fragile X syndrome: First evidence of this concept is that the expression of an autoinhibitory domain of PAK3, which targets all three group I PAKs improves the cellular and behavioral phenotype of Fmr1 KO mice, a model of Fragile X syndrome (Hayashi et al., 2007).